WallStreetZenWallStreetZen

NASDAQ: DCPH
Deciphera Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for DCPH

Based on 5 analysts offering 12 month price targets for Deciphera Pharmaceuticals Inc.
Min Forecast
$16.00-37.16%
Avg Forecast
$23.24-8.72%
Max Forecast
$26.00+2.12%

Should I buy or sell DCPH stock?

Based on 5 analysts offering ratings for Deciphera Pharmaceuticals Inc.
Hold
Strong Buy
1 analysts 20%
Buy
0 analysts 0%
Hold
4 analysts 80%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their DCPH stock forecasts and price targets.

DCPH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-30
lockedlocked$00.00+00.00%2024-04-29
lockedlocked$00.00+00.00%2024-04-29
lockedlocked$00.00+00.00%2024-03-20
lockedlocked$00.00+00.00%2024-02-07

1 of 1

Forecast return on equity

Is DCPH forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.27%

Forecast return on assets

Is DCPH forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

DCPH revenue forecast

What is DCPH's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$198.7M+13.59%
Avg 2 year Forecast
$261.1M+49.28%
Avg 3 year Forecast
$375.0M+114.4%
DCPH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DCPH revenue growth forecast

How is DCPH forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
27.95%
Industry
8.21%
Market
9.95%
DCPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DCPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DCPH vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
DCPH$25.46$23.24-8.72%Hold
AMPH$43.48$60.00+37.99%Strong Buy
AMRX$6.82$8.25+20.97%Strong Buy
INDV$16.97$37.00+118.03%Buy
BHC$6.77$11.00+62.48%Hold
View Top Pharmaceutical Stocks

Deciphera Pharmaceuticals Stock Forecast FAQ

Is Deciphera Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: DCPH) stock is to Hold DCPH stock.

Out of 5 analysts, 1 (20%) are recommending DCPH as a Strong Buy, 0 (0%) are recommending DCPH as a Buy, 4 (80%) are recommending DCPH as a Hold, 0 (0%) are recommending DCPH as a Sell, and 0 (0%) are recommending DCPH as a Strong Sell.

If you're new to stock investing, here's how to buy Deciphera Pharmaceuticals stock.

What is DCPH's revenue growth forecast for 2024-2026?

(NASDAQ: DCPH) Deciphera Pharmaceuticals's forecast annual revenue growth rate of 27.95% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 8.21%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.95%.

Deciphera Pharmaceuticals's revenue in 2024 is $174,910,000.On average, 7 Wall Street analysts forecast DCPH's revenue for 2024 to be $17,180,873,165, with the lowest DCPH revenue forecast at $16,145,063,972, and the highest DCPH revenue forecast at $17,935,116,593. On average, 7 Wall Street analysts forecast DCPH's revenue for 2025 to be $22,578,962,765, with the lowest DCPH revenue forecast at $18,670,162,355, and the highest DCPH revenue forecast at $34,330,960,884.

In 2026, DCPH is forecast to generate $32,428,575,976 in revenue, with the lowest revenue forecast at $21,100,137,168 and the highest revenue forecast at $62,305,937,826.

What is DCPH's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: DCPH) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of N/A.

What is DCPH's Price Target?

According to 5 Wall Street analysts that have issued a 1 year DCPH price target, the average DCPH price target is $23.24, with the highest DCPH stock price forecast at $26.00 and the lowest DCPH stock price forecast at $16.00.

On average, Wall Street analysts predict that Deciphera Pharmaceuticals's share price could fall to $23.24 by Apr 30, 2025. The average Deciphera Pharmaceuticals stock price prediction forecasts a potential downside of 8.72% from the current DCPH share price of $25.46.

What is DCPH's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: DCPH) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.